"New Guidelines Released for Chronic Coronary Disease by AHA/ACC"
The American Heart Association (AHA) and the American College of Cardiology (ACC) have issued updated guidelines for managing patients with chronic coronary disease (CCD). The guidelines recommend changes in the use of beta-blockers, the inclusion of SGLT2 inhibitors and GLP-1 receptor agonists for select patients, and the use of statins as first-line therapy for lipid lowering. They also suggest shorter durations of dual antiplatelet therapy and discourage the use of nonprescription or dietary supplements. Revascularization is recommended in specific scenarios, and routine periodic testing is not recommended. The guidelines emphasize the importance of patient-centered care and shared decision-making.
